EP300 single nucleotide polymorphism rs20551 correlates with prolonged overall survival in diffuse large B cell lymphoma patients treated with R-CHOP

[21] Pfreundschuh M(2008)The structural basis of protein acetylation by the p300/CBP transcriptional coactivator Nature 451 846-850

[22] Schubert J(2000)Mutations truncating the EP300 acetylase in human cancers Nat Genet 24 300-303

[23] Ziepert M(2004)The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells Nature 432 635-639

[24] Schmits R(2005)BCL6 interacts with the transcription factor Miz-1 to suppress the cyclin-dependent kinase inhibitor p21 and cell cycle arrest in germinal center B cells Nat Immunol 6 1054-1060

[25] Mohren M(2011)Multilocus association of genetic variants in MLL, CREBBP, EP300, and TOP2A with childhood acute lymphoblastic leukemia in Hispanics from Texas Cancer Epidemiol Biomark Prev 20 1204-1212

[26] Lengfelder E(2012)A constitutional variant in the transcription factor EP300 strongly influences the clinical outcome of patients submitted to allo-SCT Bone Marrow Transpl 47 1206-1211

[27] Reiser M(2000)CBP/p300 in cell growth, transformation, and development Genes Dev 14 1553-1577

[28] Nickenig C(1997)Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain Cell 90 595-606

[29] Clemens M(2008)Acetylation is indispensable for p53 activation Cell 133 612-626

[30] Peter N(2003)Stimulation of c-MYC transcriptional activity and acetylation by recruitment of the cofactor CBP EMBO Rep 4 484-490

[21] Pfreundschuh M(2008)The structural basis of protein acetylation by the p300/CBP transcriptional coactivator Nature 451 846-850

[22] Schubert J(2000)Mutations truncating the EP300 acetylase in human cancers Nat Genet 24 300-303

[23] Ziepert M(2004)The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells Nature 432 635-639

[24] Schmits R(2005)BCL6 interacts with the transcription factor Miz-1 to suppress the cyclin-dependent kinase inhibitor p21 and cell cycle arrest in germinal center B cells Nat Immunol 6 1054-1060

[25] Mohren M(2011)Multilocus association of genetic variants in MLL, CREBBP, EP300, and TOP2A with childhood acute lymphoblastic leukemia in Hispanics from Texas Cancer Epidemiol Biomark Prev 20 1204-1212

[26] Lengfelder E(2012)A constitutional variant in the transcription factor EP300 strongly influences the clinical outcome of patients submitted to allo-SCT Bone Marrow Transpl 47 1206-1211

[27] Reiser M(2000)CBP/p300 in cell growth, transformation, and development Genes Dev 14 1553-1577

[28] Nickenig C(1997)Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain Cell 90 595-606

[29] Clemens M(2008)Acetylation is indispensable for p53 activation Cell 133 612-626

[30] Peter N(2003)Stimulation of c-MYC transcriptional activity and acetylation by recruitment of the cofactor CBP EMBO Rep 4 484-490